Abstract:Background & aims: The relationship between dietary fatty acids (FA) and clinical outcomes are relatively lacking in non-dialyzed and dialyzed chronic kidney disease (CKD) population, resulting in insufficient guide about the dietary FA intake in this population. In this study, we aimed to observe the association between the intake of total or different types of FA and all-cause and cardiovascular (CV) mortality in patients undergoing peritoneal dialysis (PD).Methods: This is a prospective cohort study with data retrospectively analyzed in 881 patients undergoing PD. Dietary FA intake measured by 3-day dietary records. The outcomes were defined as all-cause and CV death. Baseline FA intake and time-averaged FA intake were categorized by tertiles based on the distribution among the study population. We used univariate and multivariate Cox proportional regression models to determine the association between amounts and types of FA and all-cause and CV mortality.Results: During a median follow up of 45 months, 93 patients were still being maintained on PD, 467 had died, including 189 (40.5%) attributable to CV death. Compared to patients in the low tertile of total FA (TFA) intake at baseline group, the middle or/and high tertile groups were more likely to be male, younger, well-educated and better nutritional status (P < 0.05). At the baseline, no association was found between all-cause and CV death in either total or different types of FA after adjusting for nutritional variables. As for time-averaged analyses, the associations of TFA, saturated FA (SFA), monounsaturated FA (MUFA), to-3 and to-6 polyunsaturated FA (PUFA) and all-cause mortality were weakened after adjustment for laboratory and nutrients variables. However, PUFA independently reduced 5% of mortality even after adjustment for laboratory and nutrients variables [HR 0.95 (0.91, 0.99), P = 0.023], and the ratio of MUFA/PUFA was positively associated with the risk for all-cause mortality [HR 1.05 (1.01, 1.09), P = 0.008]. Furthermore, each 10% increase of the ratio of to-6/to-3 was only weakly associated with the risk for all-cause mortality [HR 1.02 (1.00, 1.04), P = 0.034]. As for CVD mortality, the impacts of total and each type of FA disappeared after adjustment for laboratory or nutrients variables.Conclusions: Time-averaged PUFA intake was independently associated with a lower risk for all-cause mortality in our PD cohort, while the higher ratio of MUFA/PUFA and to-6/to-3 increased all-cause mortality. More observational and interventional researches are needed to determine these associations.(c) 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Evaluation of serum free fatty acids in chronic renal failure: evidence from a rare case with undetectable serum free fatty acids and population data

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

High Circulating Fibroblast Growth Factor-21 Levels as a Prognostic Marker in Fatty Pancreas Patients

High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

Serum Fetuin A Level is Associated with Nonalcoholic Fatty Liver Disease in Chinese Population

Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients

MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden

The Dysregulation of Eicosanoids and Bile Acids Correlates with Impaired Kidney Function and Renal Fibrosis in Chronic Renal Failure

Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

Longitudinal analysis of clinical and laboratory biomarkers in a patient with Familial Lecithin: Cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: a case study.

Urine liver fatty acid binding protein and chronic kidney disease progression

Fatty acid‐binding protein‐3 and renal function decline in patients with chronic coronary syndrome

Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure

Effect of animal versus plant omega-3 polyunsaturated fatty acids on serum level of fetuin-A in patients with chronic renal failure; a randomized double-blinded parallel clinical trial

Clinic-Pathologic Features and Renal Outcome of Fabry Disease: Data from a Chinese Cohort.

Dietary Fatty Acids Intake and All-Cause and Cardiovascular Mortality in Patients on Peritoneal Dialysis.

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease

Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.

Serum Free Fatty Acids Are Associated with Severe Coronary Artery Calcification, Especially in Diabetes: a Retrospective Study

Serum Insulin-Like Growth Factor 1 Level and Nutritional Assessment in Nondialytic Patients with Chronic Renal Failure.

Associations Of Serum Fibroblast Growth Factor 23 With Dyslipidemia And Carotid Atherosclerosis In Chronic Kidney Disease Stages 3-5d